Survey-based aging clock MindAge receives public release

Latest articles

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

Click the globe for translations.

Deep Longevity launches its MindAge psychological aging clock to the wider world – building on the data of over 250,000 people who have already used it to determine their psychological pace of aging.

Hong Kong-based Deep Longevity, which is wholly owned by Endurance RP Ltd, is developing explainable AI systems to track the rate of aging at the molecular, cellular, tissue, organ, system and physiological levels. Now it has psychological aging in its sights as well.

Longevity.Technology: Mens sana in corpore sano – Juvenal would have approved of Deep Longevity’s take on lifespan, healthspan and wellness. When it comes to tracking, measuring and attempting to twiddle the dials of aging, Deep Longevity’s range of clocks covers all the bases, and it is good to see mental health afforded equal footing. The idea that true longevity can only be achieved through improving both physical and mental wellbeing has taken off, with investor Christian Angermayer announcing a $120 million fund focused on mental health ventures and iamYiam scaling up its workforce wellbeing platform.

Deep Longevity has been developing a broad range of biomarkers of aging to maintain physical health and wellness, restore youthfulness and improve mental health and wellbeing. To that end, it has launched its MindAge© psychological aging clock.

The MindAge tests are now available via the Deep Longevity website and via the Young.AI iPhone app available in the Apple Appstore. It builds on the recently published paper PsychoAge and SubjAge: Development of Deep Biomarkers of Psychological
and Subjective Age Using Artificial Intelligence.

Deep Longevity also announced the formation of a Scientific Advisory Board (SAB) comprised of certain experts in longevity biotechnology. Chaired by Alex Zhavoronkov, PhD, the Chief Longevity Officer of Deep Longevity, the SAB will help direct and review the company’s work in the development and applications of deep biomarkers of human aging.

Deep Longevity’s SAB is a longevity Who’s Who, including Dr Eric Verdin (CEO of the Buck Institute for Research on Aging), Dr Daniel Kraft (Stanford & Harvard trained physician-scientist, Founder of Exponential Medicine,  Chair of XPrize Pandemic Alliance Task force), Dr Morten Scheibye-Knudsen (head of the Biology of Aging Laboratory and professor at the University of Copenhagen), Dr Vadim Gladyshev (Head of the Gladyshev Laboratory at Harvard University) and Dr Wei-Wu He (Chairman of Human Longevity, Inc).

Among the board, Deep Longevity executed two Consulting Agreements with recognised leaders in the fields of longevity biotechnology and longevity medicine, Drs Verdin and Gladyshev in respect of the provision of scientific and business advisory services to Deep Longevity. They will receive an award of 1,670,000 and 1,110,000 Consultant Shares, respectively, which shares will be subject to certain vesting conditions.

Jim Mellon
Jim Mellon, Chairman of the board of directors of Endurance Longevity.

Jim Mellon, Chairman of the board of directors of Endurance Longevity commented: “The scientific advisors of Deep Longevity are some of the highest-impact scientists, medical doctors, and most well-known experts in longevity. Under their leadership and supervision, the company will continue developing and commercializing the biological and psychological aging clocks and engaging in research with the academic and medical institutions as well as with the insurance companies worldwide”.

Alex Zhavoronkov, founder and Chief Longevity Officer, of Deep Longevity said: “Productive longevity is the most important asset we have in this life and Deep Longevity is dedicated to the measurement of aging at every level from biological to psychological. I am very happy to see the company expanding into the psychology of aging as it impacts our physical and mental health and well-being and is one of the areas we can control and intervene in.”

Images courtesy of Deep Longevity and Jim Mellon
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

At-home blood test powers personalised longevity advice

AgeRate develops proprietary DNA methylation clock and mobile app solution to offer users personalised longevity support. Canadian startup AgeRate is aiming to shake up the...

Researchers find warning signs for dementia in the blood

Levels of certain microRNAs indicate risk for cognitive decline. Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules in the...

Age and aging have critical effects on the gut microbiome

Research finds that aging produces significant changes in the microbiome of the human small intestine. Researchers at Cedars-Sinai have found that aging produces significant changes...

New cell-type deconvolution method for saliva created

TruDiagnostic has announced their newest research project: expanding and validating a new cellular deconvolution method to separate epithelial cells from immune cells in saliva...

Occuity raises over £2.5m for optical diabetes devices

UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development. DISCLOSURE:...